Market cap
$7 Mln
Market cap
$7 Mln
Revenue (TTM)
$3 Mln
P/E Ratio
--
P/B Ratio
1.9
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-1.4 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-0.3
Debt to Equity
0.1
Book Value
$3.4
EPS
$-121.5
Face value
--
Shares outstanding
1,291,465
CFO
$-86.36 Mln
EBITDA
$-110.49 Mln
Net Profit
$-117.42 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Applied DNA Sciences (APDN)
| -98.0 | -12.7 | 29.3 | -97.6 | -85.8 | -77.3 | -64.4 |
|
BSE Sensex*
| -8.5 | 5.3 | -5.9 | -3.4 | 8.2 | 9.3 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Applied DNA Sciences (APDN)
| -66.8 | -62.7 | -58.7 | -21.2 | 21.7 | -73.8 | -74.7 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA... Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. The company was founded in 1983 and is headquartered in Stony Brook, New York. Read more
Chairman, President & CEO
Dr. James A. Hayward Ph.D., Sc.D.
Chairman, President & CEO
Dr. James A. Hayward Ph.D., Sc.D.
Headquarters
Stony Brook, NY
Website
The share price of Applied DNA Sciences Inc (APDN) is $3.09 (NASDAQ) as of 08-Dec-2025 09:30 EDT. Applied DNA Sciences Inc (APDN) has given a return of -85.84% in the last 3 years.
Since, TTM earnings of Applied DNA Sciences Inc (APDN) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.03
|
1.14
|
|
2024
|
-1.65
|
1.26
|
|
2023
|
-0.08
|
0.17
|
|
2022
|
-0.08
|
0.05
|
|
2021
|
-0.13
|
0.18
|
The 52-week high and low of Applied DNA Sciences Inc (APDN) are Rs 190.80 and Rs 2.13 as of 29-Apr-2026.
Applied DNA Sciences Inc (APDN) has a market capitalisation of $ 7 Mln as on 08-Dec-2025. As per SEBI classification, it is a Small Cap company.
Before investing in Applied DNA Sciences Inc (APDN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.